NADPH oxidase

Last updated
NAD(P)H oxidase
Identifiers
EC no. 1.6.3.1
CAS no. 77106-92-4
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Search
PMC articles
PubMed articles
NCBI proteins
Ferric reductase
Identifiers
SymbolNADPH oxidase
Pfam PF01794
InterPro IPR013130
TCDB 5.B.1
OPM superfamily 464
OPM protein 5o05
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary

NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase) is a membrane-bound enzyme complex that faces the extracellular space. It can be found in the plasma membrane as well as in the membranes of phagosomes used by neutrophil white blood cells to engulf microorganisms. Human isoforms of the catalytic component of the complex include NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and DUOX2. [1]

Contents

Reaction

Overall reaction for the formation of superoxide from NADPH Figure 1. Overall reaction for the formation of superoxide from NADPH.png
Overall reaction for the formation of superoxide from NADPH

NADPH oxidase catalyzes the production of a superoxide free radical by transferring one electron to oxygen from NADPH. [2]

NADPH + 2O2 ↔ NADP+ + 2O2 + H+

Types

In mammals, NADPH oxidase is found in two types: one in white blood cells (neutrophilic) and the other in vascular cells, differing in biochemical structure and functions. [3] Neutrophilic NADPH oxidase produces superoxide almost instantaneously, whereas the vascular enzyme produces superoxide in minutes to hours. [4] Moreover, in white blood cells, superoxide has been found to transfer electrons across the membrane to extracellular oxygen, while in vascular cells, the radical anion appears to be released mainly intracellularly. [5] [6]

Neutrophilic type

The isoform found in neutrophils is made up of six subunits. These subunits are:

Vascular type

There are several vascular isoforms of the complex which use paralogs the NOX2 subunit:

Thyroid type

There are two further paralogs of NOX2 subunit in the thyroid:

Structure

Vascular NAD(P)H generating a superoxide (coloured by subunit). Figure 2. Vascular NAD(P)H generating a superoxide.png
Vascular NAD(P)H generating a superoxide (coloured by subunit).

The whole structure of the membrane-bound vascular enzyme is composed of five parts: two cytosolic subunits (p47phox and p67phox), a cytochrome b558 which consists of gp91phox, p22phox and a small G protein Rac. [3] Generation of the superoxide in vascular NADPH occurs by a one-electron reduction of oxygen via the gp91phox subunit, using reduced NADPH as the electron donor. The small G protein carries an essential role in the activation of the oxidase by switching between a GDP-bound (inactive) and GTP-linked (active) forms. [8]

Biological function

NADPH oxidases (NOXes) are one of the major sources of cellular reactive oxygen species (ROS), and they still are the focus of extensive research interest due to their exclusive function in producing ROS under normal physiological conditions. The NADPH oxidase complex is dormant under normal circumstances but is activated to assemble in the membranes during respiratory burst. The activated NADPH oxidase generates superoxide which has roles in animal immune response and plant signalling. [9]

Superoxide can be produced in phagosomes which have ingested bacteria and fungi, or it can be produced outside of the cell. [10] In macrophages, superoxide kills bacteria and fungi by mechanisms that are not yet fully understood. [11] [12] Superoxide spontaneously dismutates to form peroxide which is then protonated to produce hydrogen peroxide. Opinions are polarised as to how the oxidase kills microbes in neutrophils. On the one hand it is thought that hydrogen peroxide acts as substrate for myeloperoxidase to produce hypochlorous acid. [13] It may also inactivate critical metabolic enzymes, initiate lipid peroxidation, damage iron-sulphur clusters, [14] and liberate redox-active iron, which allows the generation of indiscriminate oxidants such as the hydroxyl radical. [12] An alternative view is that the oxidase elevates the pH in the vacuole to about 9.0, which is optimal for the neutral proteases that degranulate from the cytoplasmic granules (where they are inactive at pH ~5.5) and it pumps potassium into the vacuole, which solubilises the enzymes, and it is the activated proteases that kill and digest the microbes. [15]

In insects, NOXes had some functions clarified. Arthropods have three NOX types (NOX4-art, an arthropod-specific p22-phox-independent NOX4, and two calcium-dependent enzymes, DUOX). [16] [17] [18] In the gut, DUOX-dependent ROS production from bacteria-stimulated Drosophila melanogaster mucosa is an important pathogen-killing mechanism [19] and can increase defecation as a defense response. [20] In Aedes aegypti, DUOX is involved in the control of the gut indigenous microbiota. [21] Rhodnius prolixus has calcium activated DUOX, which is involved in eggshell hardening, [22] and NOX5, which is involved in the control of gut motility and blood digestion. [23] [24]

Regulation

Careful regulation of NADPH oxidase activity is crucial to maintain a healthy level of ROS in the body. The enzyme is dormant in resting cells but becomes rapidly activated by several stimuli, including bacterial products and cytokines. [25] Vascular NADPH oxidases are regulated by a variety of hormones and factors known to be important players in vascular remodeling and disease. These include thrombin, platelet-derived growth factor (PDGF), tumor necrosis factor (TNFa), lactosylceramide, interleukin-1, and oxidized LDL. [26] It is also stimulated by agonists and arachidonic acid. [26] Conversely, assembly of the complex can be inhibited by apocynin and diphenylene iodonium. Apocynin decreases influenza-induced lung inflammation in mice in vivo and so may have clinical benefits in the treatment of influenza. [27]

Ang-1 triggers NOX2, NOX4, and the mitochondria to release ROS and that ROS derived from these sources play distinct roles in the regulation of the Ang-1/Tie 2 signaling pathway and pro-angiogenic responses. [28]

Pathology

Superoxides are crucial in killing foreign bacteria in the human body. Consequently, under-activity can lead to an increased susceptibility to organisms such as catalase-positive microbes, and over-activity can lead to oxidative stress and cell damage.

Excessive production of ROS in vascular cells causes many forms of cardiovascular disease including hypertension, atherosclerosis, myocardial infarction, and ischemic stroke. [29] Atherosclerosis is caused by the accumulation of macrophages containing cholesterol (foam cells) in artery walls (in the intima). ROS produced by NADPH oxidase activate an enzyme that makes the macrophages adhere to the artery wall (by polymerizing actin fibers). This process is counterbalanced by NADPH oxidase inhibitors, and by antioxidants. An imbalance in favor of ROS produces atherosclerosis. In vitro studies have found that the NADPH oxidase inhibitors apocynin and diphenyleneiodonium, along with the antioxidants N-acetyl-cysteine and resveratrol, depolymerized the actin, broke the adhesions, and allowed foam cells to migrate out of the intima. [30] [31]

One study suggests a role for NADPH oxidase in ketamine-induced loss of neuronal parvalbumin and GAD67 expression. [32] Similar loss is observed in schizophrenia, and the results may point at the NADPH oxidase as a possible player in the pathophysiology of the disease. [33] Nitro blue tetrazolium is used in a diagnostic test, in particular, for chronic granulomatous disease, a disease in which there is a defect in NADPH oxidase; therefore, the phagocyte is unable to make the reactive oxygen species or radicals required for bacterial killing, resulting in bacteria thriving within the phagocyte. The higher the blue score the better the cell is at producing reactive oxygen species.

It has also been shown that NADPH oxidase plays a role in the mechanism that induces the formation of sFlt-1, a protein that deactivates certain proangiogenic factors that play a role in the development of the placenta, by facilitating the formation of reactive oxygen species, which are suspected intermediaries in sFlt-1 formation. These effects are in part responsible for inducing pre-eclampsia in pregnant women [34]

Mutations

Mutations in the NADPH oxidase subunit genes cause several Chronic Granulomatous Diseases (CGD), characterized by extreme susceptibility to infection. [26] These include:

In these diseases, cells have a low capacity for phagocytosis, and persistent bacterial infections occur. Areas of infected cells are common, granulomas. A similar disorder called neutrophil immunodeficiency syndrome is linked to a mutation in the RAC2, also a part of the complex.

Inhibition

NADPH oxidase can be inhibited by apocynin, nitric oxide (NO), and diphenylene iodonium. Apocynin acts by preventing the assembly of the NADPH oxidase subunits. Apocynin decreases influenza-induced lung inflammation in mice in vivo and so may have clinical benefits in the treatment of influenza. [27]

Inhibition of NADPH oxidase by NO blocks the source of oxidative stress in the vasculature. NO donor drugs (nitrovasodilators) have therefore been used for more than a century to treat coronary artery disease, hypertension, and heart failure by preventing excess superoxide from deteriorating healthy vascular cells. [3]

More advanced NADPH oxidase inhibitors include GKT-831 (Formerly GKT137831), a dual Inhibitor of isoforms NOX4 and NOX1 [35] which was patented in 2007. [36] The compound was initially developed for Idiopathic pulmonary fibrosis and obtained orphan drug designation by the FDA and EMA at end of 2010. [37]

Related Research Articles

<span class="mw-page-title-main">Chronic granulomatous disease</span> Hereditary disease group

Chronic granulomatous disease (CGD), also known as Bridges–Good syndrome, chronic granulomatous disorder, and Quie syndrome, is a diverse group of hereditary diseases in which certain cells of the immune system have difficulty forming the reactive oxygen compounds used to kill certain ingested pathogens. This leads to the formation of granulomas in many organs. CGD affects about 1 in 200,000 people in the United States, with about 20 new cases diagnosed each year.

<span class="mw-page-title-main">Reactive oxygen species</span> Highly reactive molecules formed from diatomic oxygen (O₂)

In chemistry and biology, reactive oxygen species (ROS) are highly reactive chemicals formed from diatomic oxygen (O2), water, and hydrogen peroxide. Some prominent ROS are hydroperoxide (O2H), superoxide (O2-), hydroxyl radical (OH.), and singlet oxygen. ROS are pervasive because they are readily produced from O2, which is abundant. ROS are important in many ways, both beneficial and otherwise. ROS function as signals, that turn on and off biological functions. They are intermediates in the redox behavior of O2, which is central to fuel cells. ROS are central to the photodegradation of organic pollutants in the atmosphere. Most often however, ROS are discussed in a biological context, ranging from their effects on aging and their role in causing dangerous genetic mutations.

<span class="mw-page-title-main">Nitric oxide synthase</span> Class of enzymes

Nitric oxide synthases (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule. It helps modulate vascular tone, insulin secretion, airway tone, and peristalsis, and is involved in angiogenesis and neural development. It may function as a retrograde neurotransmitter. Nitric oxide is mediated in mammals by the calcium-calmodulin controlled isoenzymes eNOS and nNOS. The inducible isoform, iNOS, involved in immune response, binds calmodulin at physiologically relevant concentrations, and produces NO as an immune defense mechanism, as NO is a free radical with an unpaired electron. It is the proximate cause of septic shock and may function in autoimmune disease.

Respiratory burst is the rapid release of the reactive oxygen species (ROS), superoxide anion and hydrogen peroxide, from different cell types.

<span class="mw-page-title-main">NOX2</span> Protein-coding gene in the species Homo sapiens

NADPH oxidase 2 (Nox2), also known as cytochrome b(558) subunit beta or Cytochrome b-245 heavy chain, is a protein that in humans is encoded by the NOX2 gene. The protein is a superoxide generating enzyme which forms reactive oxygen species (ROS).

<span class="mw-page-title-main">Apocynin</span> Chemical compound

Apocynin, also known as acetovanillone, is a natural organic compound structurally related to vanillin. It has been isolated from a variety of plant sources and is being studied for its variety of pharmacological properties.

<span class="mw-page-title-main">SOD2</span> Enzyme

Superoxide dismutase 2, mitochondrial (SOD2), also known as manganese-dependent superoxide dismutase (MnSOD), is an enzyme which in humans is encoded by the SOD2 gene on chromosome 6. A related pseudogene has been identified on chromosome 1. Alternative splicing of this gene results in multiple transcript variants. This gene is a member of the iron/manganese superoxide dismutase family. It encodes a mitochondrial protein that forms a homotetramer and binds one manganese ion per subunit. This protein binds to the superoxide byproducts of oxidative phosphorylation and converts them to hydrogen peroxide and diatomic oxygen. Mutations in this gene have been associated with idiopathic cardiomyopathy (IDC), premature aging, sporadic motor neuron disease, and cancer.

<span class="mw-page-title-main">Reactive nitrogen species</span>

Reactive nitrogen species (RNS) are a family of antimicrobial molecules derived from nitric oxide (•NO) and superoxide (O2•−) produced via the enzymatic activity of inducible nitric oxide synthase 2 (NOS2) and NADPH oxidase respectively. NOS2 is expressed primarily in macrophages after induction by cytokines and microbial products, notably interferon-gamma (IFN-γ) and lipopolysaccharide (LPS).

<span class="mw-page-title-main">NOX1</span> Protein-coding gene in the species Homo sapiens

NADPH oxidase 1 is an enzyme that in humans is encoded by the NOX1 gene.

<span class="mw-page-title-main">NOX4</span> Protein-coding gene in the species Homo sapiens

NADPH oxidase 4 is an enzyme that in humans is encoded by the NOX4 gene, and is a member of the NOX family of NADPH oxidases.

<span class="mw-page-title-main">Cytochrome b-245, alpha polypeptide</span> Protein-coding gene in the species Homo sapiens

Cytochrome b-245 light chain is a protein that in humans is encoded by the CYBA gene involved in superoxide production and phagocytosis.

Leukotriene B<sub>4</sub> receptor 2 Protein-coding gene in humans

Leukotriene B4 receptor 2, also known as BLT2, BLT2 receptor, and BLTR2, is an Integral membrane protein that is encoded by the LTB4R2 gene in humans and the Ltbr2 gene in mice.

<span class="mw-page-title-main">Neutrophil cytosolic factor 4</span> Protein-coding gene in the species Homo sapiens

Neutrophil cytosol factor 4 is a protein that in humans is encoded by the NCF4 gene.

<span class="mw-page-title-main">Dual oxidase 2</span> Protein-coding gene in the species Homo sapiens

Dual oxidase 2, also known as DUOX2 or ThOX2, is an enzyme that in humans is encoded by the DUOX2 gene. Dual oxidase is an enzyme that was first identified in the mammalian thyroid gland. In humans, two isoforms are found; hDUOX1 and hDUOX2. The protein location is not exclusive to thyroid tissue; hDUOX1 is prominent in airway epithelial cells and hDUOX2 in the salivary glands and gastrointestinal tract.

<span class="mw-page-title-main">Dual oxidase 1</span> Protein-coding gene in the species Homo sapiens

Dual oxidase 1, also known as DUOX1 or ThOX1, is an enzyme which in humans is encoded by the DUOX1 gene. DUOX1 was first identified in the mammalian thyroid gland. In humans, two isoforms are found; hDUOX1 and hDUOX2. Human DUOX protein localization is not exclusive to thyroid tissue; hDUOX1 is prominent in airway epithelial cells and hDUOX2 in the salivary glands and gastrointestinal tract.

<span class="mw-page-title-main">NOX5</span> Protein-coding gene in the species Homo sapiens

NADPH oxidase, EF-hand calcium binding domain 5, also known as NOX5, is a protein which in humans is encoded by the NOX5 gene.

<span class="mw-page-title-main">NOX3</span> Protein-coding gene in the species Homo sapiens

NADPH oxidase 3 is an enzyme that in humans is encoded by the NOX3 gene.

p22phox Protein, also known as the human neutrophil cytochrome b light chain (CYBA), is an essential component of the membrane-associated enzyme phagocyte NADPH-oxidase This enzyme uses NADH or NADPH as the electron donor for the one electron reduction of oxygen to produce superoxide anion, a reactive oxygen species (ROS), and a functionally important step for the antimicrobial activity of phagocytic cells. p22phox is also expressed in many other human cells such as endothelial and vascular smooth muscle cells, including those within the coronary arteries. Specific polymorphisms of the CYBA gene have been identified that are associated with a decreased risk of coronary artery disease (CAD).

Neutrophil oxidative burst test is a measure of neutrophil oxidation and is a useful assay in the diagnosis of chronic granulomatous disease and is also a useful means to determine the overall metabolic integrity of phagocytosing neutrophils. The NADPH oxidase enzyme is missing in CGD. From total blood, neutrophils can be purified and the NADPH oxidase activity can be measured with different methods in these cells after activation. Phagocytosis by polymorphonuclear neutrophils and monocytes constitutes an essential arm of host defense against bacterial or fungal infections. The phagocytic process can be separated into several major stages: chemotaxis, attachment of particles to the cell surface of phagocytes, ingestion (phagocytosis) and intracellular killing by oxygen-dependent and oxygen-independent mechanisms.

Edgar Pick is an Israeli immunologist who is Professor Emeritus of Immunology in the Department of Clinical Microbiology and Immunology at the Faculty of Medical and Health Sciences at Tel Aviv University, Israel.

References

  1. Sahoo S, Meijles DN, Pagano PJ (March 2016). "NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?". Clinical Science. 130 (5): 317–335. doi:10.1042/CS20150087. PMC   4818578 . PMID   26814203.
  2. Panday A, Sahoo MK, Osorio D, Batra S (January 2015). "NADPH oxidases: an overview from structure to innate immunity-associated pathologies". Cellular & Molecular Immunology. 12 (1): 5–23. doi:10.1038/cmi.2014.89. PMC   4654378 . PMID   25263488.
  3. 1 2 3 Dusting GJ, Selemidis S, Jiang F (March 2005). "Mechanisms for suppressing NADPH oxidase in the vascular wall". Memórias do Instituto Oswaldo Cruz. 100 (Suppl 1): 97–103. doi: 10.1590/S0074-02762005000900016 . hdl: 1807/8204 . PMID   15962105.
  4. Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK (August 1998). "Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts". Hypertension. 32 (2): 331–337. doi: 10.1161/01.hyp.32.2.331 . PMID   9719063.
  5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (June 1994). "Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells". Circulation Research. 74 (6): 1141–1148. doi: 10.1161/01.res.74.6.1141 . PMID   8187280.
  6. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al. (September 1998). "Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy". Hypertension. 32 (3): 488–495. doi: 10.1161/01.hyp.32.3.488 . PMID   9740615.
  7. Herb M (February 2024). "NADPH oxidase 3: Beyond the innear ear". Antioxidants. 13 (2). doi: 10.3390/antiox13020219 . PMC   10886416 .
  8. Heyworth PG, Knaus UG, Settleman J, Curnutte JT, Bokoch GM (November 1993). "Regulation of NADPH oxidase activity by Rac GTPase activating protein(s)". Molecular Biology of the Cell. 4 (11): 1217–1223. doi:10.1091/mbc.4.11.1217. PMC   275755 . PMID   8305740.
  9. Sharma, Pallavi; Jha, Ambuj Bhushan; Dubey, Rama Shanker; Pessarakli, Mohammad (2012-04-24). "Reactive Oxygen Species, Oxidative Damage, and Antioxidative Defense Mechanism in Plants under Stressful Conditions". Journal of Botany. 2012: 1–26. doi: 10.1155/2012/217037 . ISSN   2090-0120.
  10. Herb M, Gluschko A, Wiegmann K, Farid A, Wolf A, Utermöhlen O, et al. (February 2019). "Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO". Science Signaling. 12 (568): eaar5926. doi: 10.1126/scisignal.aar5926 . PMID   30755476.
  11. Herb M, Schramm M (February 2021). "Functions of ROS in Macrophages and Antimicrobial Immunity". Antioxidants. 10 (2): 313. doi: 10.3390/antiox10020313 . PMC   7923022 . PMID   33669824.
  12. 1 2 Slauch JM (May 2011). "How does the oxidative burst of macrophages kill bacteria? Still an open question". Molecular Microbiology. 80 (3): 580–583. doi:10.1111/j.1365-2958.2011.07612.x. PMC   3109634 . PMID   21375590.
  13. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM (February 2013). "Myeloperoxidase: a front-line defender against phagocytosed microorganisms". Journal of Leukocyte Biology. 93 (2): 185–198. doi:10.1189/jlb.0712349. PMC   3545676 . PMID   23066164.
  14. Djaman O, Outten FW, Imlay JA (October 2004). "Repair of oxidized iron-sulfur clusters in Escherichia coli". The Journal of Biological Chemistry. 279 (43): 44590–44599. doi: 10.1074/jbc.M406487200 . PMID   15308657.
  15. Levine AP, Segal AW (August 2016). "The NADPH Oxidase and Microbial Killing by Neutrophils, With a Particular Emphasis on the Proposed Antimicrobial Role of Myeloperoxidase within the Phagocytic Vacuole". Microbiology Spectrum. 4 (4). doi: 10.1128/microbiolspec.MCHD-0018-2015 . PMID   27726789.
  16. Gandara AC, Torres A, Bahia AC, Oliveira PL, Schama R (March 2017). "Evolutionary origin and function of NOX4-art, an arthropod specific NADPH oxidase". BMC Evolutionary Biology. 17 (1): 92. Bibcode:2017BMCEE..17...92G. doi: 10.1186/s12862-017-0940-0 . PMC   5372347 . PMID   28356077.
  17. Kawahara T, Quinn MT, Lambeth JD (July 2007). "Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes". BMC Evolutionary Biology. 7 (1): 109. Bibcode:2007BMCEE...7..109K. doi: 10.1186/1471-2148-7-109 . PMC   1940245 . PMID   17612411.
  18. Gandara, Ana Caroline P.; Oliveira, Pedro L. (2023), Pick, Edgar (ed.), "NADPH Oxidases in Arthropods", NADPH Oxidases Revisited: From Function to Structure, Cham: Springer International Publishing, pp. 477–488, doi:10.1007/978-3-031-23752-2_28, ISBN   978-3-031-23751-5 , retrieved 2023-10-19
  19. Ha EM, Oh CT, Bae YS, Lee WJ (November 2005). "A direct role for dual oxidase in Drosophila gut immunity". Science. 310 (5749): 847–850. Bibcode:2005Sci...310..847H. doi:10.1126/science.1117311. PMID   16272120. S2CID   12476863.
  20. Du EJ, Ahn TJ, Kwon I, Lee JH, Park JH, Park SH, et al. (January 2016). Miguel-Aliaga I (ed.). "TrpA1 Regulates Defecation of Food-Borne Pathogens under the Control of the Duox Pathway". PLOS Genetics. 12 (1): e1005773. doi: 10.1371/journal.pgen.1005773 . PMC   4699737 . PMID   26726767.
  21. Oliveira JH, Gonçalves RL, Lara FA, Dias FA, Gandara AC, Menna-Barreto RF, et al. (March 2011). Schneider DS (ed.). "Blood meal-derived heme decreases ROS levels in the midgut of Aedes aegypti and allows proliferation of intestinal microbiota". PLOS Pathogens. 7 (3): e1001320. doi: 10.1371/journal.ppat.1001320 . PMC   3060171 . PMID   21445237.
  22. Dias FA, Gandara AC, Queiroz-Barros FG, Oliveira RL, Sorgine MH, Braz GR, Oliveira PL (December 2013). "Ovarian dual oxidase (Duox) activity is essential for insect eggshell hardening and waterproofing". The Journal of Biological Chemistry. 288 (49): 35058–35067. doi: 10.1074/jbc.M113.522201 . PMC   3853258 . PMID   24174530.
  23. Montezano AC, De Lucca Camargo L, Persson P, Rios FJ, Harvey AP, Anagnostopoulou A, et al. (June 2018). "NADPH Oxidase 5 Is a Pro-Contractile Nox Isoform and a Point of Cross-Talk for Calcium and Redox Signaling-Implications in Vascular Function". Journal of the American Heart Association. 7 (12). doi:10.1161/JAHA.118.009388. PMC   6220544 . PMID   29907654.
  24. Gandara AC, Dias FA, de Lemos PC, Stiebler R, Bombaça AC, Menna-Barreto R, Oliveira PL (2021-02-25). ""Urate and NOX5 Control Blood Digestion in the Hematophagous Insect Rhodnius prolixus"". Frontiers in Physiology. 12: 633093. doi: 10.3389/fphys.2021.633093 . PMC   7947236 . PMID   33716782.
  25. Geiszt M (July 2006). "NADPH oxidases: new kids on the block". Cardiovascular Research. 71 (2): 289–299. doi: 10.1016/j.cardiores.2006.05.004 . PMID   16765921.
  26. 1 2 3 Griendling KK, Sorescu D, Ushio-Fukai M (March 2000). "NAD(P)H oxidase: role in cardiovascular biology and disease". Circulation Research. 86 (5): 494–501. doi: 10.1161/01.res.86.5.494 . PMID   10720409.
  27. 1 2 Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR, Selemidis S (February 2011). "Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation". PLOS Pathogens. 7 (2): e1001271. doi: 10.1371/journal.ppat.1001271 . PMC   3033375 . PMID   21304882.
  28. Harel S, Mayaki D, Sanchez V, Hussain SN (May 2017). "NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells". Vascular Pharmacology. 92: 22–32. doi:10.1016/j.vph.2017.03.002. PMID   28351775.
  29. Wattanapitayakul SK, Bauer JA (February 2001). "Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications". Pharmacology & Therapeutics. 89 (2): 187–206. doi:10.1016/S0163-7258(00)00114-5. PMID   11316520.
  30. Park YM, Febbraio M, Silverstein RL (January 2009). "CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima". The Journal of Clinical Investigation. 119 (1): 136–145. doi:10.1172/JCI35535. PMC   2613464 . PMID   19065049.
  31. Curtiss LK (March 2009). "Reversing atherosclerosis?". The New England Journal of Medicine. 360 (11): 1144–1146. doi:10.1056/NEJMcibr0810383. PMID   19279347.
  32. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (December 2007). "Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase". Science. 318 (5856): 1645–1647. Bibcode:2007Sci...318.1645B. doi:10.1126/science.1148045. PMID   18063801. S2CID   41932041.
  33. Tom Fagan. Does Oxidative Stress Link NMDA and GABA Hypotheses of Schizophrenia? Archived 2007-12-30 at the Wayback Machine Schizophrenia Research Forum. December 09, 2007.
  34. Huang QT, Zhang M, Zhong M, Yu YH, Liang WZ, Hang LL, et al. (December 2013). "Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia". Placenta. 34 (12): 1177–1182. doi:10.1016/j.placenta.2013.09.017. PMID   24144948.
  35. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, et al. (December 2012). "Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent". Hepatology. 56 (6): 2316–2327. doi:10.1002/hep.25938. PMC   3493679 . PMID   22806357.
  36. "Espacenet - Bibliographic data". worldwide.espacenet.com. Retrieved 2017-05-04.
  37. "FDA granting Genkyotex Orphan Drug Designation of GKT137831 for IPF - Genkyotex S.A." pauahosting.co.nz. Retrieved 2017-05-04.[ permanent dead link ]